Abstract 2954: CS5007: A novel EGFR and HER3 dual-targeted antibody-drug conjugate (ADC) with potent antitumor activity in preclinical studies
Chuan Wang(Qilu Hospital of Shandong University), Jianxin Yang(Ascepion Pharmaceuticals (China)), Yi Sun(Ascepion Pharmaceuticals (China)), Ning Zhang(Ascepion Pharmaceuticals (China)), Yaxin Chen(China Pharmaceutical University), Yamin Wang(Ascepion Pharmaceuticals (China)), Xuelian Liu(Ascepion Pharmaceuticals (China)), Yongli Yang(Southwest Forestry University), Xinling Zhang(Dalian Maritime University), Yongwang Li(Tianjin University), Fei Ma(Ascepion Pharmaceuticals (China)), Mengyao Zhu(Ascepion Pharmaceuticals (China))
Cited by 0
Related Papers
Photoimmobilized Ni Clusters Boost Photodehydrogenative Coupling of Amines to Imines via Enhanced Hydrogen Evolution Kinetics
|ACS Catalysis|2020|97
Facile synthesis of self-assembled ultrathin α-FeOOH nanorod/graphene oxide composites for supercapacitors
|Journal of Colloid and Interface Science|2017|63
PIEZO1 Ion Channel Mediates Ionizing Radiation-Induced Pulmonary Endothelial Cell Ferroptosis via Ca2+/Calpain/VE-Cadherin Signaling
|Frontiers in Molecular Biosciences|2021|60
Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration
|British Journal of Cancer|2014|52